美國FDA批準的CAR-T隻針對某幾種淋巴癌.

來源: 於 2023-12-12 15:33:03 [舊帖] [給我悄悄話] 本文已被閱讀：次

. CAR T-cell therapies are FDA approved for:

  • Aggressive relapsed or refractory large B-cell lymphoma including diffuse large B cell lymphoma (DLBCL), primary mediastinal B-cell lymphoma, high-grade B-cell lymphoma, and transformed follicular lymphoma.
  • Relapsed or refractory mantle cell lymphoma
  • Relapsed or refractory follicular lymphoma